Risperidone Augmentation for Treatment-Resistant Aggression in ADHD

Phase 4 Completed 25 enrolled Armenteros, Jorge L., M.D., P.A. Janssen, LP · collab

RandomizedParallel-groupDouble-blindTreatment

Summary

Primary objectives: 1. To assess the short-term efficacy of risperidone augmentation for treatment-resistant aggression in children with ADHD. 2. To assess the short-term safety and tolerability of risperidone augmentation in the same group of subjects.

Timeline

Start: 2003-01
Primary completion: —
Completion: 2005-04

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Risperidone	Other / unclassified	—	—

Indications

No indication recorded.